Progress Towards a Gold Standard for Gene Therapy Research
Advancements in cell and gene therapy products are beginning to pave the way for program developers at an early stage. It’s crucial to keep the end product in mind from the beginning of the process. This webinar is a roundtable discussion featuring a panel of experts across the CGT space who will discuss the concept-to-cure pathway and insights on navigating challenges from different perspectives (development, manufacturing, testing).
Watch now to learn:
- Key differences between material requirements for research vs. GMP vectors
- The importance of standardizing materials and manufacturing processes
- Real-world examples of how the pathway to the clinic can be streamlined
About the Presenters
James Cody, PhD
Associate Director, Technical Evaluations, Charles River
Lisa Kirkwood
Associate Director, Analytical, AAVantgarde Bio
Phil Vanek, PhD
Chief Technology Officer, Gamma Biosciences
Samarendra Mohanty
President and Chief Scientific Officer, Nanoscope
Victor Hernandez
CSO, Axovia Therapeutics